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A 40-year-old female presented to the emergency department (ED) after the acute onset of 
dyspnea. The patient was tachypneic with accessory muscle usage and diffuse wheezing on initial 
examination. Despite aggressive treatment, the patient deteriorated and was intubated. This case 
takes the reader through the differential diagnosis and systematic workup of a patient presenting to 
the ED with dyspnea and arrives at the unexpected cause for this patient’s presentation. [Clin Pract 
Cases Emerg Med. 2021;5(1):1–5.] 
Keywords: Dyspnea; adenoid cystic carcinoma; CPC.
CASE PRESENTATION (DR. KEBORT)
A 40-year-old female presented to the emergency 
department (ED) with sudden onset dyspnea. She stated she 
had been having progressive shortness of breath over two 
weeks that worsened acutely just prior to her presentation. The 
patient also reported a cough productive of yellow/brown 
mucus over the same time course. 
The patient had a past medical history of severe persistent 
asthma for which she was on multiple inhalers including 
albuterol sulfate, fluticasone/vilanterol, tiotropium bromide, 
and ipratropium bromide. She also had a history of seasonal 
allergies for which she was on dexamethasone nasal spray, 
fluticasone nasal spray, levocetirizine, ranitidine, and 
montelukast. She had been using these regularly during her 
illness with no improvement in symptoms. She recently saw 
her pulmonologist who found that she had elevated peripheral 
eosinophils in her blood work and started her on her first 
injection of mepolizumab. 
In addition to asthma, the patient had a medical history 
of gastroesophageal reflux for which she took pantoprazole, 
hypertension for which she took losartan, and depression for 
which she took fluoxetine. She had no surgical history. The 
patient was a former smoker who had quit nine years earlier. 
She denied any illicit drug use and reported only social 
alcohol use. She worked as a nurse at the same location for 
University of Maryland Medical Center, Department of Emergency Medicine, 
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the prior three years. Her only allergies were to escitalopram 
and lettuce.
On arrival to the ED, the patient was noted to be in 
significant respiratory distress with increased work of 
breathing. She was afebrile (37.5º Celsius) with a heart rate of 
135 beats per minute, a respiratory rate of 38 breaths per 
minute, an oxygen saturation of 100% on room air, and a 
blood pressure of 160/98 millimeters of mercury. She weighed 
88.9 kilograms (kg) and was five feet, five inches in height 
with a body mass index of 32.6 kg/meter2. She was well 
developed and well nourished. Her head was normocephalic 
and atraumatic with moist mucous membranes, a clear 
oropharynx with no uvular edema, tonsillar enlargement or 
audible stridor. Her neck was supple with no tender 
lymphadenopathy, and her trachea was midline. She was 
tachycardic but had a regular rhythm with no murmurs, rubs, 
or gallops. She was tachypneic and had accessory muscle 
usage with diffuse wheezing, greatest at the bases. Her 
abdomen was obese but soft and nontender. She had trace 
lower extremity edema bilaterally with normal dorsalis pedis 
pulses. Her lower extremities had no asymmetry or calf 
tenderness. She had a Glasgow Coma Scale score of 15 with 
no motor or sensory deficits. 
An electrocardiogram was performed, which showed 
sinus tachycardia with a normal axis, normal intervals, and no 
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ST-segment or T-wave changes. Her chest radiography (CXR) 
is shown (Image 1). Her initial laboratory results are shown in 
Tables 1 and 2.
The patient received inhaled albuterol 0.083% 5 
milligrams (mg) and ipratropium 500 micrograms with 2 
grams of intravenous magnesium and solumedrol 125 mg in 
the ED without significant improvement and with increasing 
fatigue and declining mental status. Approximately one hour 
after her arrival to the ED, the patient was intubated using 
ketamine and rocuronium for presumed status asthmaticus 
without complication. She was started on broad spectrum 
antibiotics due to concern for possible pneumonia given her 
failure to improve. She was admitted to the intensive care unit 
(ICU). A test was then done that revealed the diagnosis.
CASE DISCUSSION (DR. HONG)
In this case, a 40-year-old obese female with a history of 
asthma presented to the ED with difficulty breathing and 
wheezing. As I read through the case, I was struck by how it 
served as a valuable reminder that we need to keep our 
differentials broad, even when the presentation may initially 
seem clear. 
Asthma is a common disease, and as emergency 
physicians we care for patients with wheezing on a near-daily 
basis and tend to follow a formulaic treatment pathway, 
generally with positive results. However, deep down we know 
that there are more causes to wheezing than just asthma and 
chronic obstructive pulmonary disease (COPD). It is crucial 
that whenever we care for a patient who is not improving with 
standard treatments we step back and reassess our plan, 
including expanding our differential diagnosis. This is 
Blood test Patient value Normal range
Complete Blood Count
White Blood Cells 12.2 K/mcL 4.5 - 11.0 K/mcL
Hemoglobin 11.5 g/dL 12.6 - 17.4 g/dL
Hematocrit 40.4% 37.0 - 50.0%









Sodium 138 mmol/L 136-145 mmol/L
Potassium 3.8 mmol/L 3.5-5.1 mmol/L
Chloride 104 mmol/L 98-107 mmol/L
Bicarbonate 26 mmol/L 21-30 mmol/L
Blood Urea Nitrogen 10 mg/dL 7-20 mg/dL
Creatinine 0.75 mg/dL 0.66-1.25 mg/dL
Glucose 249 mg/dL 70-99 mg/dL
Magnesium 2.2 mg/dL 1.6-2.6 mg/dL
Phosphorus 3.3 mg/dL 2.5-4.5 mg/dL
Total Protein 5.5 g/dL 6.3-8.2 g/dL
Albumin 3.1 g/dL 3.5-5.2 g/dL
Total Bilirubin 0.3 mg/dL 0.3-1.2 mg/dL
Aspartate 
Aminotransferase
13 u/L 17-59 u/L
Alanine Aminotransferase 24 u/L 21-72 u/L
Alkaline Phosphatase 49 u/L 38-126 u/L
Lactic Acid 0.9 mmol/L 0.5-1 mmol/L
Coagulation Studies
Prothrombin Time 13.3 s 10.8-13.3 s
Partial Thromboplastin 
Time
23.3 s 31.4-48.0 s
International Normalized  
Ratio
1.1
Table 1. Complete blood cell count, serum chemistry and coagulation 
studies of a 40-year-old female with sudden onset dyspnea.
K, thousand; mcL, microliter; g, grams; dL, deciliter; mmoL, 
millimole; L, liter; mg, milligrams; u, units; s, seconds.
important even when a patient’s presentation seems as though 
it should be straightforward.
After reading the case presentation, my immediate 
concern for the patient was her severe respiratory distress 
complicated by respiratory failure requiring intubation. The 
physical exam was concerning for impending respiratory 
failure due to fatigue, and the ED team took the appropriate 
course of action in intubating the patient prior to 
Image 1. Chest radiograph of a 40-year-old female with sudden 
onset dyspnea.
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decompensation. As emergency clinicians we must never 
forget the basics of resuscitation and the need to address our 
ABCs in emergency medicine.
In this case the patient had a history a severe persistent 
asthma for which she was on multiple medications including 
short-acting and long-acting beta-agonists; inhaled 
corticosteroids; montelukast; and she had recently been started 
on mepolizumab, an interleukin-5 antagonist 
immunomodulator used in more severe cases of eosinophilic 
asthma.1 Despite her disease severity, a two-week course of 
symptoms with acute worsening in the setting of medication 
compliance struck me as unusual. A productive cough 
combined with minimal response to advanced asthma 
treatments suggested that her wheezing and respiratory failure 
was not caused by her asthma alone and that there was another 
process at play.
At this point I felt I needed to take a step back and 
reconsider the information I had been presented. Although the 
patient was noted to be tachypneic on exam with increased 
work of breathing, her oxygen saturation was 100% on room 
air and her venous blood gas pH of 7.36 showed no acidosis, 
both unusual for an asthma exacerbation severe enough to 
require intubation. Her partial pressure of carbon dioxide 
(pCO2) was elevated, but the lack of acidosis suggested a 
more chronic process as the cause of her respiratory failure 
rather than a severe acute asthma exacerbation. As I 
considered the many causes of wheezing, I eliminated 
diagnoses based on the information available.
While there are many causes of wheezing, there are some 
that could be quickly ruled out based on the patient’s history 
and physical exam. The physical exam did not note any goiter, 
or enlargement or asymmetry of the neck. Tonsillar 
hypertrophy, vascular rings, and bronchiolitis were all unlikely 
causes of wheezing in an adult. As the patient had no history of 
recent surgery or intubations and had no history of chronic 
upper airway inflammation, I reasoned that tracheal stenosis, 
tracheomalacia, and mucous plugging were unlikely to be the 
cause of the patient’s wheezing. Vocal cord edema was unlikely 
as the patient had no stridor or history of voice changes, and, 
per the ED course she was intubated without any issue. 
Given the two-week duration of symptoms and lack of 
any pertinent history, I removed anaphylaxis from the 
Table 2. Venous blood gas of 40-year-old female with sudden 
onset dyspnea.
Patient value Normal range
pH 7.30 7.31-7.41
pCO2 51 mm Hg 41-51 mm Hg
pO2 108 mm Hg 36-42 mm Hg
HCO3 29 mmol/L 23-29 mmol/L
pH, potential of hydrogen; mm Hg, millimeters mercury; pCO2, 
partial pressure of carbon dioxide; pO2, partial pressure of oxygen; 
HCO3, bicarbonate.
differential. I also felt that a foreign body was unlikely to be 
the cause of the patient’s symptoms. While it is possible to 
have a foreign body present for a prolonged period these are 
usually small and unlikely to eventually cause acute severe 
airway compromise. The excellent social history provided by 
the medical team helped rule out occupational exposures such 
as bird feces, farming chemicals, or silicosis.
Besides the blood gas, the patient’s laboratory studies did 
not offer insight into the cause of her symptoms. The CXR 
was overall unremarkable with the exception of the correct 
placement of the endotracheal tube. While not diagnostic, I 
would have expected a patient with respiratory failure due to 
asthma or COPD to have more hyperinflated lungs than seen 
on this CXR. There was no sign of a focal infiltrate suggestive 
of an infectious cause such as bacterial pneumonia or 
aspergillosis. There were no signs of pulmonary edema on 
imaging. Given the patient’s lack of history of heart failure I 
felt comfortable ruling out cardiac causes as the reason for her 
wheezing. While not a common cause of wheezing, I 
considered pulmonary embolism (PE) as the patient was 
tachypneic, tachycardic, and in respiratory distress. Using the 
revised Geneva score she would be in the moderate risk group, 
warranting a D-dimer. However, she was neither hypoxic nor 
hypotensive, unusual for a PE large enough to cause such a 
significant degree of respiratory failure. Further workup for a 
PE was therefore not pursued. 
At this point I was left with a handful of diagnoses: tumor; 
autoimmune causes such as eosinophilic granulomatous 
polyangiitis (EGPA); and infectious causes primarily from 
pulmonary parasitic infections. While the patient’s history of 
asthma put her at higher risk for autoimmune diseases like 
EGPA, she lacked the characteristic extrapulmonary findings 
such as rash, granulomatous skin lesions, nasal polyps, or 
recurrent sinusitis.2,3 Her elevated eosinophil count made 
pulmonary parasitic infections such as Löffler’s syndrome more 
likely. Löffler’s syndrome can present insidiously, but the 
reticulonodular pulmonary opacities typically associated with 
the disease were not seen on this patient’s CXR. This disease is 
also rare in the United States, and most of the reported cases are 
associated with rural living.4 All in all, I felt that Löffler’s 
syndrome would be unlikely. 
It can be challenging to narrow a broad differential 
diagnosis down to a single diagnosis. However, the patient’s 
smoking history gave me pause as smoking is an independent 
risk factor for all types of head and neck cancers.5,6 These 
cancers often slowly grow in size and can cause both 
wheezing and severe respiratory distress, depending on their 
location. After considering a broad differential of potential 
causes of wheezing, I determined the patient likely had local 
neck pathology causing an obstruction of the trachea. 
If I were the treating physician, I would obtain a 
computed tomography (CT) of the soft tissue of the neck and 
chest with intravenous contrast to evaluate for an obstructive 
mass, most likely in the trachea.
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CASE OUTCOME (DR. KEBORT)
After failing to be weaned off the ventilator despite trials of 
antibiotics, nebulizers, furosemide, terbutaline, and 
aminophylline, additional imaging was done. The diagnostic 
study was a CT of the chest. As read by the radiologist, there 
was a soft tissue mass involving the carina projecting into the 
lumen of the distal trachea measuring approximately two cubic 
centimeters (cm) (Image 2) for which direct visualization was 
recommended. Rigid bronchoscopy showed a large tracheal 
tumor, which was extensively debulked (Image 3). 
The patient was extubated two days after debulking. Her 
final pathology showed adenoid cystic carcinoma. She had a 
positron emission tomography (PET) revealing no 
metastases. Repeat bronchoscopy performed approximately 
one month later revealed tumor involvement extending two 
cm from the main carina into the proximal left mainstem 
bronchus as well as the proximal opening of the bronchus 
intermedius and into the distal trachea; no lymph nodes 
sampled were positive for malignant involvement. The 
patient was deemed to not be a surgical candidate given the 
extensive airway involvement. She underwent concurrent 
chemoradiation with weekly carboplatin and paclitaxel as 
well as proton radiation therapy. Her follow-up CT imaging 
showed stable irregularity along the tracheal bifurcation with 
post-radiation changes. She gets repeat CT imaging every 
three months for continued surveillance. 
RESIDENT DISCUSSION
Primary tracheal tumors are exceedingly rare as the 
majority of tumors found in the trachea are due to invasion 
from local tissues including lung, esophagus, or thyroid. In 
total, primary tracheal tumors account for less than 0.1% of all 
malignant tumors.7 In adults, more than 80% of these primary 
tracheal tumors are malignant.8 Multiple studies show 
malignant tracheal tumors are more likely to occur in males 
and usually in the fifth or sixth decades of life.9
The most common types of malignant tracheal tumors 
include squamous cell carcinoma (SCC), adenoid cystic 
carcinoma (ACC), and carcinoid tumors. Cigarette smoking is 
a common risk factor for the development of SCC, known to 
be a fast-growing malignancy. With SCC, the tumor can grow 
into the mucosa, which can lead to bleeding within the trachea 
and hemoptysis. ACC has less of a potential to invade the 
mucosa with bleeding occurring significantly less often.7
Despite differences in histology, these malignant tumors 
present in a similar way with symptoms of airway 
obstruction being by far the most common. However, these 
symptoms do not usually occur until at least 50% of the 
airway is occluded, which can lead to a significant delay in 
diagnosis. SCC is typically diagnosed within four to six 
months of initial symptom onset with the most common 
presentation of hemoptysis, occurring in about 60% of 
patients with SCC, given its ability to invade the mucosa.10 
ACC is not diagnosed until an average of 18 months after 
symptom onset, commonly being misdiagnosed as adult 
onset asthma due to its overlapping of symptoms of dyspnea 
on exertion and wheezing.7,8
The ED workup, as with any patient with new respiratory 
symptoms, includes a CXR. In addition to identifying lung 
pathology, the CXR can evaluate for any significant tracheal 
narrowing. Sensitivity of a CXR is poor with a sensitivity of 
only 66% when there is a known tracheal mass and can be as 
low as 20% without a known diagnosis as tracheal tumors can 
be easily overlooked.11 A CT of the chest is usually the next 
diagnostic step. This can depict the area of obstruction, degree 
of stenosis, vascular involvement, as well as identify any 
surrounding lymphadenopathy.10 
If a tracheal mass is identified on CT imaging, the next 
diagnostic step is a bronchoscopy for histologic testing and 
confirmation.12 After tissue sampling, PET scans are typically 
performed for staging of the malignancy although there is no 
widely accepted staging system in place for tracheal tumors.8
Initial management in the ED most importantly included 
management of the patient’s airway. A smaller-bore 
endotracheal tube than is typically used in the ED should be 
selected to prevent a forceful, traumatic airway or inability to 
pass the endotracheal tube. Steroids do not play a beneficial 
role in airway obstruction in the setting of tracheal tumors and 
Image 2. Coronal (A) and sagittal (B) computed tomography of 
the chest without contrast of a 40-year-old female with dyspnea 
showing a mass at the carina (1). (Trachea with endotracheal tube 
[2] is marked to orient the reader.)
Image 3. Bronchoscopy images (A, B) of a 40-year-old female 
with dyspnea showing the carinal mass (1), and the left (2) and 
right (3) main bronchi. Post-surgical bronchoscopy (C) shows 
improved cross-sectional diameter of the left (2) and right (3) main 
bronchi, as well as the area of the resection (4).
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are therefore not recommended. If a patient had previously 
been misdiagnosed with asthma and was previously being 
treated with steroids, these should be discontinued prior to any 
possible resection.11
The main treatment for all types of tracheal 
malignancies includes resection. However, the maximum 
length of tissue resection in a trachea is five cm, potentially 
limiting the full ability to resect it depending on the extent 
of the tumor. Additional contraindications to surgical 
resection of these malignancies include multiple confirmed 
positive lymph nodes, involvement of greater than 50% the 
length of the trachea, mediastinal invasion of unresectable 
organs, and distant metastases.7 Approximately 50-70% of 
patients will have resectable disease at their time of 
diagnosis.9 Chemoradiation may be offered in some cases. 
However, there is a dearth of data regarding its role in 
treatment of tracheal tumors. At this time, a similar 
approach is taken to tracheal tumors as those of other 
tumors with head and neck origin with administration of 
cisplatin every 21 days along with radiation.9 For tumors 
that are unresectable, rigid bronchoscopy may be performed 
with laser partial resection or placement of stents, however 
only as a palliative approach. 
The strongest prognostic factor for these patients is the 
degree of resectability. Squamous cell carcinoma has a worse 
prognosis with a five-year survival of only 13%. Despite 
ACC being diagnosed usually significantly later than SCC, 
with its relatively slow growth and more prolonged course, 
patients with these tumors have an increased five-year 
survival of 74%.13
FINAL DIAGNOSIS
Tracheal adenoid cystic carcinoma, complicated by 
respiratory failure.
KEY TEACHING POINTS
• When a patient with dyspnea is not improving with 
standard treatments, reevaluate and reconsider your 
differential diagnosis. 
• Symptoms of tracheal obstruction, such as from a tumor, 
typically do not present until approximately half of the 
airway is occluded, which can lead to a delay in diagnosis. 
• Initial testing for a tracheal mass includes CXR followed 
by CT. If a mass is found, bronchoscopy should be 
performed for direct visualization and tissue sampling.
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